Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil versus placebo for cognitive testing performance in cholinesterase-naive Alzheimer's disease
2008-003377-41Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Alzheimer's disease (AD) comparing Donepezil with Placebo (2 arms). Primary endpoints: CogState composite score, CogState composite score at additional timepoints and 1 more. Started Aug 2008; status: completed.
02
Drugs
donepezil
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on 2008-003377-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003377-41.